ENDRA Life Sciences initial beneficial ownership statement lists ASP Isotopes as 10% owner

• ENDRA Life Sciences Form 3 shows ASP Isotopes, via LHE LNG Holdings, as a 10% owner with 66,846 common shares.
• Holdings also include 511,541 pre-funded warrants exercisable at $0.0001, with no expiration.
• Position includes warrants for 1,156,774 shares at $6.57, expiring May 27, 2031; exercisability tied to stockholder approval.
• Event date listed as Oct. 1, 2026; filing signed Oct. 8, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-006129), on October 08, 2026, and is solely responsible for the information contained therein.